Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Prof. Dr. Meinrad Beer, Director of the Clinic for Diagnostic and Interventional Radiology, University Hospital Ulm

Prof. Meinrad Beer

mint Lesion™ has become an indispensable part of our tumor boards and clinical trials. It significantly strengthens the recognition of radiology and the cooperation between imaging departments and with clinical partners.

Related Resources

Related Resources

New iRECIST whitepaper published

We are happy to present our newly published whitepaper on iRECIST and its application. This is available here on our homepage as well as on www.irecis…

University Hospital Ulm: Pilot study shows discriminatory power of MRI-based 3d texture analysis for bone lesions

Distinguishing between enchondroma, a benign tumor, and low-grade chondrosarcoma, which is a low-aggressivity malignancy, is a frequent challenge, as…

4 Questions – 4 Answers // Imaging in Clinical Trials

Mint Medical, Inc. Vice President of Clinical Trials, Kelie Luby Discusses Advances in Imaging Analysis in Clinical Trials and What’s Next for Mint…